Google-backed Cal­i­co dou­bles down on an­ti-ag­ing R&D pact with Ab­b­Vie as part­ners ante up $1B, start to de­tail drug tar­gets

Sev­en years af­ter strik­ing up a ma­jor R&D al­liance, Ab­b­Vie and Google-backed an­ti-ag­ing spe­cial­ist Cal­i­co are dou­bling down on their work with a joint, $1 bil­lion com­mit­ment to con­tin­u­ing their work to­geth­er. And they’re al­so be­gin­ning to of­fer some de­tails on where this project is tak­ing them in the clin­ic.

Ac­cord­ing to their state­ment, each of the two play­ers is putting up $500 mil­lion more to keep the labs hum­ming.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER